Secondary Logo

Journal Logo


doi: 10.1097/IAE.0b013e31818c93b8

In a recent article “Bevacizumab (Avastin) for Stage 3 Retinopathy of Prematurity in Zone I or Posterior Zone II” Retina. 28(6):831–838, June 2008 co-authored by Helen Ann Mintz-Hittner, M.D., and Ronald R. Kuppel, Jr., M.D., the authors stated that they had obtained IRB approval to perform their retrospective case series. We have learned that IRB approval was obtained for the review and presentation of some of the cases presented in this series but not all. We would like to make our readership aware of this fact.

© The Ophthalmic Communications Society, Inc.